Haleon (HLN) Income from Non-Controlling Interests (2021 - 2023)

Haleon (HLN) posted Income from Non-Controlling Interests of $64.5 million for Q4 2023, up 203.39% on a QoQ basis from $21.3 million in Q2 2023, and up 17.07% year-over-year from $55.1 million in Q4 2022.

Haleon (HLN) Income from Non-Controlling Interests (2021 - 2023) Analysis & Trends

Haleon's Income from Non-Controlling Interests history runs 3 years deep, the most recent figure standing at $64.5 million for Q4 2023.

  • Quarterly Income from Non-Controlling Interests rose 17.07% year-over-year to $64.5 million in Q4 2023, while the trailing twelve-month figure through Dec 2023 was $172.7 million (changed N/A YoY) and the FY2025 annual result came in at $17.1 million, down 59.37% from the prior year.
  • Income from Non-Controlling Interests was $64.5 million for Q4 2023 at Haleon, up from $21.3 million in the prior quarter.
  • Across five years, Income from Non-Controlling Interests topped out at $64.5 million in Q4 2023 and bottomed at $21.3 million in Q2 2023.
  • A 3-year average of $43.3 million and a median of $43.6 million in 2021 frame the typical range for Income from Non-Controlling Interests.
  • Annual changes were most pronounced in 2022 — Income from Non-Controlling Interests increased 2.24% — and 2023, when it advanced 17.07%.
  • Haleon's Income from Non-Controlling Interests stood at $53.9 million in 2021, then climbed by 2.24% to $55.1 million in 2022, then rose by 17.07% to $64.5 million in 2023.
  • Business Quant data shows HLN's Income from Non-Controlling Interests at $64.5 million in Q4 2023, $21.3 million in Q2 2023, and $31.8 million in Q2 2023.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Inc. Minority (Qtr)
1 Haleon 89.06 Bn 87.19 Bn - -
2 Teva Pharmaceutical Industries 35.92 Bn 32.18 Bn 1.97 Bn -
3 Zoetis 32.51 Bn 30.57 Bn 1.62 Bn -
4 Takeda Pharmaceutical 27.56 Bn 23.49 Bn 4.39 Bn 395,346.10
5 United Therapeutics 23.18 Bn 21.03 Bn 648.10 Mn -
6 RedHill Biopharma 21.76 Bn 21.76 Bn - -
7 Viatris 20.28 Bn 18.48 Bn 1.16 Bn -
8 Neurocrine Biosciences 17.75 Bn 16.43 Bn 800.70 Mn -12.70 Mn
9 Elanco Animal Health 12.63 Bn 12.21 Bn 785.00 Mn -
10 Vireo Growth 10.48 Bn 10.33 Bn 59.30 Mn 3.60 Mn

Historic Data

Download Data
DateValue
Dec 31, 2023 64.54 Mn
Jun 30, 2023 21.27 Mn
May 3, 2023 31.79 Mn
Dec 31, 2022 55.13 Mn
Sep 20, 2022 33.24 Mn
Dec 31, 2021 53.92 Mn